|
US6897220B2
(en)
|
2001-09-14 |
2005-05-24 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
CA2465978C
(en)
|
2001-09-14 |
2015-04-07 |
Soon Hyung Woo |
Inhibitors of histone deacetylase
|
|
JP4648628B2
(ja)
|
2002-03-13 |
2011-03-09 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ヒストンデアセチラーゼの新規な阻害剤としてのカルボニルアミノ誘導体
|
|
CN100396679C
(zh)
|
2002-03-13 |
2008-06-25 |
詹森药业有限公司 |
用作组蛋白脱乙酰化酶抑制剂的哌嗪基、哌啶基和吗啉基衍生物
|
|
WO2003076401A1
(en)
|
2002-03-13 |
2003-09-18 |
Janssen Pharmaceutica N.V. |
Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
|
|
CA2476583C
(en)
|
2002-03-13 |
2011-07-05 |
Kristof Van Emelen |
Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
|
|
AU2004276337B2
(en)
|
2003-09-24 |
2009-11-12 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
US7253204B2
(en)
|
2004-03-26 |
2007-08-07 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
HRP20120327T1
(hr)
|
2004-07-28 |
2012-05-31 |
Janssen Pharmaceutica Nv |
Supstituirani indolil alkil amino derivati kao novi inhibitori histonske deacetilaze
|
|
CA2577947A1
(en)
|
2004-08-31 |
2006-03-09 |
Banyu Pharmaceutical Co., Ltd. |
Novel substituted imidazole derivative
|
|
HN2005000795A
(es)
*
|
2004-10-15 |
2010-08-19 |
Aventis Pharma Inc |
Pirimidinas como antagonistas del receptor de prostaglandina d2
|
|
US7642275B2
(en)
|
2004-12-16 |
2010-01-05 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
CA2605110A1
(en)
|
2005-04-20 |
2006-11-02 |
Merck & Co., Inc. |
Benzothiophene derivatives
|
|
JP2008536925A
(ja)
|
2005-04-20 |
2008-09-11 |
メルク エンド カムパニー インコーポレーテッド |
ベンゾチオフェンヒドロキサム酸誘導体
|
|
AU2006240246A1
(en)
|
2005-04-20 |
2006-11-02 |
Merck Sharp & Dohme Corp. |
Benzothiophene hydroxamic acid derivatives with carbamate, urea, amide and sulfonamide substitutions
|
|
JP2008540574A
(ja)
|
2005-05-11 |
2008-11-20 |
タケダ サン ディエゴ インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
|
DK1885710T3
(en)
|
2005-05-18 |
2015-11-23 |
Janssen Pharmaceutica Nv |
SUBSTITUTED AMINOPROPENYLPIPERIDINE OR MORPHOLINE DERIVATIVES AS UNKNOWN INHIBITORS OF HISTONDEACETYLASE
|
|
WO2008041053A2
(en)
|
2005-05-20 |
2008-04-10 |
Methylgene, Inc. |
Inhibitors of vegf receptor and hgf receptor signaling
|
|
DE102005027274A1
(de)
*
|
2005-06-08 |
2006-12-14 |
Schering Ag |
Inhibitoren der löslichen Adenylatzyklase
|
|
US7417066B2
(en)
|
2005-06-08 |
2008-08-26 |
Schering Ag |
Inhibitors of soluble adenylate cyclase
|
|
AU2006262166A1
(en)
|
2005-06-24 |
2007-01-04 |
Merck Sharp & Dohme Corp. |
Modified malonate derivatives
|
|
CA2615105A1
(en)
|
2005-07-14 |
2007-01-25 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
GB0521244D0
(en)
|
2005-10-19 |
2005-11-30 |
Astrazeneca Ab |
Benzamide compounds
|
|
AR057579A1
(es)
|
2005-11-23 |
2007-12-05 |
Merck & Co Inc |
Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
|
|
AU2007208495A1
(en)
*
|
2006-01-12 |
2007-08-02 |
Merck Sharp & Dohme Corp. |
Hydroxyalkylarylamide derivatives
|
|
EP1976835A2
(en)
*
|
2006-01-13 |
2008-10-08 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
JP5225103B2
(ja)
|
2006-01-19 |
2013-07-03 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ヒストン・デアセチラーゼの新規なインヒビターとしてのヘテロシクリルアルキル誘導体
|
|
DK1981875T3
(da)
|
2006-01-19 |
2014-07-14 |
Janssen Pharmaceutica Nv |
Substituerede indolylalkylaminoderivater som inhibitorer af histondeacetylase
|
|
ES2327972T3
(es)
|
2006-01-19 |
2009-11-05 |
Janssen Pharmaceutica, N.V. |
Derivados de aminofenil como nuevos inhibidores de histona deacetilasa.
|
|
EP1979326B1
(en)
|
2006-01-19 |
2012-10-03 |
Janssen Pharmaceutica N.V. |
Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
|
|
EP1979327A1
(en)
|
2006-01-19 |
2008-10-15 |
Janssen Pharmaceutica, N.V. |
Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
|
|
US7888360B2
(en)
|
2006-01-19 |
2011-02-15 |
Janssen Pharmaceutica N.V. |
Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
|
|
US8168658B2
(en)
|
2006-02-28 |
2012-05-01 |
Merck Sharp & Dohme Corp. |
Inhibitors of histone deacetylase
|
|
WO2007127137A2
(en)
|
2006-04-26 |
2007-11-08 |
Merck & Co., Inc. |
Disubstituted aniline compounds
|
|
CA2651681A1
(en)
*
|
2006-05-18 |
2007-11-29 |
Merck & Co., Inc. |
Aryl-fused spirocyclic compounds
|
|
JP2009544611A
(ja)
|
2006-07-20 |
2009-12-17 |
メルク エンド カムパニー インコーポレーテッド |
ヒストン脱アセチル化酵素阻害剤としてのリン誘導体
|
|
WO2008029152A2
(en)
*
|
2006-09-08 |
2008-03-13 |
Summit Corporation Plc |
Treatment of duchenne muscular dystrophy
|
|
US7977336B2
(en)
|
2006-12-28 |
2011-07-12 |
Banyu Pharmaceutical Co. Ltd |
Aminopyrimidine derivatives as PLK1 inhibitors
|
|
TW200911757A
(en)
*
|
2007-01-18 |
2009-03-16 |
Takeda San Diego Inc |
Crystalline forms of histone deacetylase inhibitors
|
|
US8030344B2
(en)
|
2007-03-13 |
2011-10-04 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
CN103087043A
(zh)
*
|
2007-03-16 |
2013-05-08 |
中国人民解放军军事医学科学院放射与辐射医学研究所 |
具有抗增殖活性的苯甲酰胺类衍生物及其药用制剂
|
|
WO2009002534A1
(en)
*
|
2007-06-26 |
2008-12-31 |
Gilead Colorado, Inc. |
Imidazopyridinyl thiazolyl histone deacetylase inhibitors
|
|
JP2010531358A
(ja)
|
2007-06-27 |
2010-09-24 |
メルク・シャープ・エンド・ドーム・コーポレイション |
ヒストン脱アセチル化酵素阻害剤としてのピリジル及びピリミジニル誘導体
|
|
WO2009002495A1
(en)
|
2007-06-27 |
2008-12-31 |
Merck & Co., Inc. |
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
|
|
CN101861151B
(zh)
*
|
2007-09-14 |
2014-08-13 |
梅特希尔基因公司 |
使用组蛋白脱乙酰基酶hdac1、hdac2和/或hdac3的选择性抑制剂和微管稳定剂的癌症组合治疗
|
|
WO2009095324A1
(en)
*
|
2008-01-29 |
2009-08-06 |
F. Hoffmann-La Roche Ag |
Novel n-(2-amino-phenyl)-amide derivatives
|
|
WO2009118370A1
(en)
|
2008-03-27 |
2009-10-01 |
Janssen Pharmaceutica Nv |
Aza-bicyclohexyl substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
|
|
AU2008355098B2
(en)
*
|
2008-04-21 |
2012-11-15 |
Gpcr Therapeutics, Inc |
Heterocyclic compounds
|
|
JP5640005B2
(ja)
|
2008-07-14 |
2014-12-10 |
ギリアード サイエンシーズ, インコーポレイテッド |
Hdacおよび/またはcdk阻害剤としてのイミダゾシルピリジン化合物
|
|
EP2303841A1
(en)
|
2008-07-14 |
2011-04-06 |
Gilead Sciences, Inc. |
Oxindolyl inhibitor compounds
|
|
EP2303881A2
(en)
|
2008-07-14 |
2011-04-06 |
Gilead Sciences, Inc. |
Fused heterocyclyc inhibitors of histone deacetylase and/or cyclin-dependent kinases
|
|
KR20110038159A
(ko)
*
|
2008-07-28 |
2011-04-13 |
길리애드 사이언시즈, 인코포레이티드 |
사이클로알킬리덴 및 헤테로사이클로알킬리덴 히스톤 데아세틸라아제 억제제 화합물
|
|
AU2009289649B2
(en)
|
2008-09-03 |
2016-05-05 |
Biomarin Pharmaceutical Inc. |
Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors
|
|
AU2009303602B2
(en)
|
2008-10-14 |
2012-06-14 |
Sunshine Lake Pharma Co., Ltd. |
Compounds and methods of use
|
|
JP2010111702A
(ja)
|
2009-02-16 |
2010-05-20 |
Tetsuya Nishio |
複素環化合物、その製造法および用途
|
|
WO2010094678A1
(en)
*
|
2009-02-23 |
2010-08-26 |
F. Hoffmann-La Roche Ag |
Novel ortho-aminoamides for the treatment of cancer
|
|
US8329907B2
(en)
*
|
2009-04-02 |
2012-12-11 |
Merck Patent Gmbh |
Autotaxin inhibitors
|
|
ES2463826T3
(es)
|
2009-06-08 |
2014-05-29 |
Gilead Sciences, Inc. |
Compuestos inhibidores de HDAC de cicloalquilcarbamato benzamida anilina
|
|
CA2763786C
(en)
|
2009-06-08 |
2014-09-30 |
Gilead Sciences, Inc. |
Alkanoylamino benzamide aniline hdac inihibitor compounds
|
|
WO2011053876A1
(en)
|
2009-10-30 |
2011-05-05 |
Massachusetts Institute Of Technology |
The use of ci-994 and dinaline for the treatment of memory/cognition and anxiety disorders
|
|
TWI429628B
(zh)
|
2010-03-29 |
2014-03-11 |
Univ Taipei Medical |
吲哚基或吲哚啉基羥肟酸化合物
|
|
US20130029846A1
(en)
|
2010-03-29 |
2013-01-31 |
Basf Se |
Fungicidal Iminoderivatives
|
|
SG10201502484SA
(en)
|
2010-03-30 |
2015-05-28 |
Verseon Corp |
Multisubstituted aromatic compounds as inhibitors of thrombin
|
|
EP2560488B1
(en)
|
2010-04-23 |
2015-10-28 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
|
AR081331A1
(es)
|
2010-04-23 |
2012-08-08 |
Cytokinetics Inc |
Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
|
|
AR081626A1
(es)
|
2010-04-23 |
2012-10-10 |
Cytokinetics Inc |
Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
|
|
MX352844B
(es)
|
2011-02-28 |
2017-12-11 |
Calitor Sciences Llc |
Compuestos de quinolina sustituidos y metodos de uso.
|
|
US8957066B2
(en)
*
|
2011-02-28 |
2015-02-17 |
Biomarin Pharmaceutical Inc. |
Histone deacetylase inhibitors
|
|
WO2012118782A1
(en)
*
|
2011-02-28 |
2012-09-07 |
Repligen Corporation |
Histone deacetylase inhibitors
|
|
US10059723B2
(en)
|
2011-02-28 |
2018-08-28 |
Biomarin Pharmaceutical Inc. |
Histone deacetylase inhibitors
|
|
ES2698847T3
(es)
*
|
2011-07-07 |
2019-02-06 |
Merck Patent Gmbh |
Azaheterociclos sustituidos para el tratamiento del cáncer
|
|
EA201490228A1
(ru)
*
|
2011-07-08 |
2014-08-29 |
Новартис Аг |
Новые производные трифторметилоксадиазола и их применение для лечения заболевания
|
|
CN104302640A
(zh)
|
2012-03-16 |
2015-01-21 |
埃克希金医药品有限公司 |
3,5-二氨基吡唑激酶抑制剂
|
|
UA112897C2
(uk)
|
2012-05-09 |
2016-11-10 |
Байєр Фарма Акцієнгезелльшафт |
Біциклічно заміщені урацили та їх застосування для лікування і/або профілактики захворювань
|
|
EP2879677B1
(en)
|
2012-07-28 |
2017-06-14 |
Calitor Sciences, LLC |
Substituted pyrazolone compounds and methods of use
|
|
TWI574962B
(zh)
|
2012-11-14 |
2017-03-21 |
加拓科學公司 |
作爲pi3激酶調節劑的芳雜環化合物及其使用方法和用途
|
|
PE20151412A1
(es)
|
2012-11-27 |
2015-10-10 |
Thomas Helledays Stiftelse For Medicinsk Forskning |
Derivados de pirimidin-2,4-diamina para el tratamiento de cancer
|
|
JP2016511237A
(ja)
|
2013-02-01 |
2016-04-14 |
アセチロン ファーマシューティカルズ インコーポレイテッドAcetylon Pharmaceuticals,Inc. |
選択的hdac3阻害剤
|
|
KR102148681B1
(ko)
|
2013-02-21 |
2020-08-27 |
칼리토르 사이언시즈, 엘엘씨 |
Pi3 키나제 모듈레이터로서의 헤테로방향족 화합물
|
|
WO2014149139A2
(en)
*
|
2013-03-15 |
2014-09-25 |
Verseon, Inc. |
Halogenopyrazoles as inhibitors of thrombin
|
|
RU2665554C2
(ru)
*
|
2013-03-15 |
2018-08-31 |
Байомарин Фармасьютикал Инк. |
Ингибиторы hdac
|
|
DK2968297T3
(en)
|
2013-03-15 |
2019-01-07 |
Verseon Inc |
MULTI-SUBSTITUTED AROMATIC COMPOUNDS AS SERINE PROTEASE INHIBITORS
|
|
CA2908542C
(en)
|
2013-04-29 |
2017-08-01 |
Chong Kun Dang Pharmaceutical Corp. |
Novel compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same
|
|
WO2015006875A1
(en)
*
|
2013-07-18 |
2015-01-22 |
Methylgene Inc. |
Process for the preparation of substituted pyrimidines
|
|
NZ631142A
(en)
|
2013-09-18 |
2016-03-31 |
Axikin Pharmaceuticals Inc |
Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
|
|
EP3062783B1
(en)
|
2013-10-18 |
2020-08-12 |
The General Hospital Corporation |
Imaging histone deacetylases with a radiotracer using positron emission tomography
|
|
RU2016129380A
(ru)
|
2013-12-20 |
2018-01-25 |
СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи |
Замещенные диаминопиримидильные соединения, их композиции и способы лечения с их участием
|
|
CN106794181A
(zh)
|
2014-06-04 |
2017-05-31 |
托马斯·黑勒戴药物研究基金会 |
用于治疗炎性和自身免疫性病况的mth1抑制剂
|
|
WO2015187088A1
(en)
|
2014-06-04 |
2015-12-10 |
Thomas Helledays Stiftelse För Medicinsk Forskning |
Mth1 inhibitors for treatment of cancer
|
|
RU2732416C2
(ru)
*
|
2014-07-31 |
2020-09-16 |
Институт Пастер Корея |
Производные 2-амино-бензимидазола и их использование в качестве ингибиторов 5-липоксигеназы и/или простагландин е-синтазы
|
|
JP2017528486A
(ja)
|
2014-09-17 |
2017-09-28 |
ヴァーセオン コーポレイション |
セリンプロテアーゼ阻害剤としてのピラゾリル置換ピリドン化合物
|
|
MY191736A
(en)
|
2014-12-23 |
2022-07-13 |
Axikin Pharmaceuticals Inc |
3,5-diaminopyrazole kinase inhibitors
|
|
ES2931460T3
(es)
|
2015-02-27 |
2022-12-29 |
Verseon Int Corporation |
Compuestos de pirazol sustituido como inhibidores de serina proteasa
|
|
BR112017028139A2
(pt)
|
2015-07-02 |
2018-08-28 |
Biomarin Pharmaceutical Inc. |
inibidores de histona desacetilase
|
|
US10308658B2
(en)
|
2015-10-19 |
2019-06-04 |
Sunshine Lake Pharma Co., Ltd. |
Salt of EGFR inhibitor, crystalline form and uses thereof
|
|
KR101838615B1
(ko)
*
|
2016-09-30 |
2018-03-15 |
숙명여자대학교산학협력단 |
신규한 벤조옥사졸 또는 벤조티아졸 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물
|
|
US10357493B2
(en)
|
2017-03-10 |
2019-07-23 |
Selenity Therapeutics (Bermuda), Ltd. |
Metalloenzyme inhibitor compounds
|
|
RU2764243C2
(ru)
|
2017-09-22 |
2022-01-14 |
ДЖУБИЛАНТ ЭПИПЭД ЭлЭлСи |
Гетероциклические соединения в качестве ингибиторов PAD
|
|
CN111225915B
(zh)
|
2017-10-18 |
2023-03-07 |
朱比兰特埃皮帕德有限公司 |
作为pad抑制剂的咪唑并吡啶化合物
|
|
US11629135B2
(en)
|
2017-11-06 |
2023-04-18 |
Jubilant Prodell Llc |
Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation
|
|
RS65576B1
(sr)
|
2017-11-24 |
2024-06-28 |
Jubilant Episcribe Llc |
Heterociklična jedinjenja kao inhibitori prmt5
|
|
CN112105610B
(zh)
|
2018-03-13 |
2024-01-26 |
朱比连特普罗德尔有限责任公司 |
作为pd1/pd-l1相互作用/活化的抑制剂的双环化合物
|
|
GB201820450D0
(en)
|
2018-12-14 |
2019-01-30 |
Z Factor Ltd |
Compound and its use for the treatment of alpha1-antitryspin deficiency
|
|
CN114727974A
(zh)
|
2019-07-30 |
2022-07-08 |
艾科尼佐治疗股份有限公司 |
Hdac6抑制剂及其用途
|
|
GB201918404D0
(en)
*
|
2019-12-13 |
2020-01-29 |
Z Factor Ltd |
Compounds and their use for the treatment of aplha1-antitrypsin deficiency
|
|
WO2022169985A1
(en)
|
2021-02-03 |
2022-08-11 |
Eikonizo Therapeutics, Inc. |
Hdac6 inhibitors and uses thereof
|
|
AU2023250964A1
(en)
|
2022-04-08 |
2024-11-07 |
Eikonizo Therapeutics, Inc. |
Oxadiazole hdac6 inhibitors and uses thereof
|